Published in Semin Thromb Hemost on January 01, 1995
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res (2010) 1.93
The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost (2004) 1.62
Comparison of thrombelastography with common coagulation tests. Thromb Haemost (1981) 1.58
Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol (2001) 1.40
Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer (1979) 1.18
Preoperative and follow-up procedures on patients with breast cancer. Cancer (1980) 1.17
Postoperative hypercoagulability and deep-vein thrombosis after laparoscopic cholecystectomy. Surg Endosc (1995) 1.14
A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis (2000) 1.10
Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost (1991) 1.09
Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost (1988) 1.03
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost (2007) 1.02
Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol (2013) 1.01
Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost (1991) 1.01
The identification of accelerated coagulability. Thromb Res (1976) 0.91
Electronic readout for three-channel thrombelastograph. J Med (1978) 0.89
The normal thromboelastogram and its interpretation. Semin Thromb Hemost (1995) 0.89
In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses. Thromb Haemost (1986) 0.88
Nonsurgical diagnosis and management of puerperal ovarian vein thrombophlebitis. Am J Obstet Gynecol (1979) 0.88
Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg (1999) 0.88
Omental anisakiasis: a rare mimic of acute appendicitis. Am J Clin Pathol (1983) 0.86
Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg (1994) 0.86
Prevention of postoperative venous thromboembolism following laparoscopic cholecystectomy. Surg Endosc (1994) 0.85
Thrombelastography of blood from subjects with chronic renal failure. Thromb Res (1987) 0.84
Risk factor assessment in the management of patients with suspected deep venous thrombosis. Int Angiol (2000) 0.84
Hematologic changes following burns. J Surg Res (1977) 0.83
Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost (1995) 0.83
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use. Int Angiol (2008) 0.83
Thromboelastographic changes in carcinoma: an animal model. J Med (1976) 0.82
Modified radical mastectomy. Cancer (1975) 0.82
Disseminated intravascular multiple systems activation (DIMSA) following thermal injury. J Trauma (1978) 0.81
Nonoperative extraction of retained common duct stones. Arch Surg (1976) 0.81
Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion (2001) 0.81
Deep vein thrombosis outcome and the level of oral anticoagulation therapy. J Vasc Surg (1999) 0.80
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thrombo-embolism in high-risk patients. Eur J Vasc Endovasc Surg (2009) 0.80
Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg (1988) 0.80
Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost (1995) 0.80
Use of progressive pneumoperitoneum in the treatment of giant abdominal hernias. Am Surg (1978) 0.80
International perspective on venous thromboembolism prophylaxis in surgery. Semin Thromb Hemost (1991) 0.79
Finding the right fit: effective thrombosis risk stratification in orthopedic patients. Orthopedics (2000) 0.79
Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution. Thromb Res (1974) 0.79
The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg (1999) 0.78
Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost (1995) 0.78
Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. Int Angiol (1993) 0.78
Thromboelastography: measuring statistical probabilities. Semin Thromb Hemost (1995) 0.78
Results of nonsurgical treatment of retained biliary calculi. Surg Gynecol Obstet (1980) 0.78
Study of oxygen transport in skeletal muscle using an unsteady state method. Bibl Anat (1973) 0.78
The haemostatic effectiveness of autologous platelet rich plasma sequestered after heparin administration and institution of cardiopulmonary bypass. Perfusion (1995) 0.77
Gas transfer and thrombogenesis in an annular membrane oxygenator with active blood mixing. Trans Am Soc Artif Intern Organs (1973) 0.77
Thrombosis prophylaxis using external compression. Surg Gynecol Obstet (1983) 0.77
An unusual complication of minidose heparin therapy. Clin Orthop Relat Res (1976) 0.77
Perspectives on thromboelastography. Semin Thromb Hemost (1995) 0.77
Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg (1996) 0.77
Matching risk with treatment strategies in deep vein thrombosis management. Blood Coagul Fibrinolysis (1999) 0.77
Iatrogenic biliary tract complications: radiologic features and clinical significance. Radiographics (1991) 0.77
Can combined (mechanical and pharmacological) modalities prevent fatal VTE? Int Angiol (2011) 0.76
Altered coagulability in cancer patients. CA Cancer J Clin (1982) 0.76
In vitro testing of surface thrombogenicity using the thrombelastograph. Res Commun Chem Pathol Pharmacol (1976) 0.76
The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty. J Arthroplasty (1999) 0.76
Modifications of plasma levels of tissue factor pathway inhibitor and endothelin-1 induced by a reverse Trendelenburg position: influence of elastic compression--preliminary results. J Vasc Surg (1995) 0.76
The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis. A randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Joint Surg Am (1991) 0.75
Follow-up adjuvant chemotherapy and chemoimmunotherapy for stage II and III carcinoma of the breast. Cancer (1982) 0.75
Computerization of three-channel thrombelastograph. J Med (1978) 0.75
Home use of impulse compression of the foot and compression stockings in the treatment of chronic venous insufficiency. J Vasc Surg (2001) 0.75
Viscoelastic effects of dextran 70 on human blood. Surg Forum (1979) 0.75
Altered coagulability in malignancy. IMJ Ill Med J (1979) 0.75
Percutaneous forceps extraction of retained biliary tract calculi. Gastrointest Radiol (1977) 0.75
Neutralization of heparin by cellular blood elements. Thromb Res (1975) 0.75
Physicians respond to question of first assistant. AORN J (1978) 0.75
Adjuvant chemotherapy for stage II and III breast carcinoma. JAMA (1980) 0.75
Multi system analysis of intravenous calcium and sodium heparin. Thromb Res (1979) 0.75
Heparin therapy - Part II. Cardiovasc Nurs (1977) 0.75
Low molecular weight heparins and external pneumatic compression as options for venous thromboembolism prophylaxis: a surgeon's perspective. Semin Thromb Hemost (1991) 0.75
Gallbladder disease: current trends and treatments. Am J Nurs (1980) 0.75
Coagulation changes in the newborn with respiratory failure. Thromb Res (1980) 0.75
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. J Surg Oncol (1984) 0.75
Heparin therapy-part I. Cardiovasc Nurs (1977) 0.75
A new forceps for removal of biliary tract stones. Surg Gynecol Obstet (1985) 0.75
Biliary peritoneal grafts. Am Surg (1980) 0.75
Unusual popliteal mass. IMJ Ill Med J (1977) 0.75
Laboratory monitoring of continuous intravenous heparin therapy. Thromb Res (1983) 0.75
Etiology, diagnosis, and treatment of recovery room bleeding/hemorrhage. Heart Lung (1985) 0.75
A model of clot growth as a function of heparin and platelet concentration. Res Commun Chem Pathol Pharmacol (1977) 0.75
Critical issues in deep vein thrombosis prevention. J Vasc Surg (2010) 0.75
Venous duplex imaging follow-up of acute symptomatic deep vein thrombosis of the leg. J Vasc Surg (1995) 0.75
Unusual popleteal mass. IMJ Ill Med J (1977) 0.75
A side-to-end choledochoduodenostomy between the common bile duct and the stump of the transected duodenum. Int Surg (1991) 0.75
Contact activation of heparinized plasma. Thromb Res (1974) 0.75
Anticoagulant kinetics following bolus injection of heparin. Thromb Haemost (1979) 0.75
Effect of platelet count and hematocrit on the coagulability of heparinized blood. Res Commun Chem Pathol Pharmacol (1978) 0.75
Workshop II: The future of prolonged thromboprophylaxis. Blood Coagul Fibrinolysis (1999) 0.75